| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Extranodal NK-T-Cell | 14 | 2024 | 17 | 2.910 |
Why?
|
| Intestinal Mucosa | 10 | 2021 | 815 | 1.380 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 371 | 1.150 |
Why?
|
| China | 16 | 2025 | 295 | 1.010 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2024 | 13 | 0.910 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2024 | 14 | 0.910 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2024 | 73 | 0.890 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2656 | 0.870 |
Why?
|
| Ephrin-B3 | 3 | 2018 | 8 | 0.870 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2025 | 1354 | 0.840 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2024 | 176 | 0.820 |
Why?
|
| Dietary Supplements | 6 | 2020 | 498 | 0.810 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 774 | 0.810 |
Why?
|
| Self Efficacy | 1 | 2024 | 205 | 0.810 |
Why?
|
| YY1 Transcription Factor | 2 | 2019 | 16 | 0.800 |
Why?
|
| 5-Methylcytosine | 1 | 2022 | 34 | 0.770 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2024 | 542 | 0.770 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2019 | 106 | 0.710 |
Why?
|
| Adenine | 1 | 2021 | 122 | 0.690 |
Why?
|
| Swine | 11 | 2021 | 1216 | 0.690 |
Why?
|
| Glycerides | 1 | 2020 | 16 | 0.670 |
Why?
|
| Drugs, Chinese Herbal | 4 | 2020 | 24 | 0.670 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 378 | 0.660 |
Why?
|
| Sensitivity and Specificity | 2 | 2024 | 2158 | 0.640 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 51 | 0.640 |
Why?
|
| DNA | 3 | 2021 | 1675 | 0.630 |
Why?
|
| Cysteine Endopeptidases | 1 | 2019 | 119 | 0.620 |
Why?
|
| Ephrin-B1 | 1 | 2018 | 9 | 0.610 |
Why?
|
| Spermidine | 1 | 2018 | 5 | 0.610 |
Why?
|
| Receptors, Eph Family | 1 | 2018 | 21 | 0.610 |
Why?
|
| Papanicolaou Test | 1 | 2019 | 36 | 0.600 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2019 | 32 | 0.600 |
Why?
|
| Antioxidants | 5 | 2021 | 378 | 0.590 |
Why?
|
| Genome | 1 | 2021 | 526 | 0.590 |
Why?
|
| Fabaceae | 1 | 2018 | 27 | 0.590 |
Why?
|
| DNA Repair | 1 | 2021 | 630 | 0.560 |
Why?
|
| Papillomaviridae | 1 | 2019 | 189 | 0.560 |
Why?
|
| Lycium | 1 | 2016 | 1 | 0.510 |
Why?
|
| Fruit | 3 | 2023 | 237 | 0.510 |
Why?
|
| Polyphenols | 1 | 2016 | 25 | 0.500 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2021 | 364 | 0.500 |
Why?
|
| Esophageal Neoplasms | 3 | 2025 | 393 | 0.500 |
Why?
|
| Triglycerides | 1 | 2018 | 613 | 0.490 |
Why?
|
| Porcine epidemic diarrhea virus | 3 | 2021 | 3 | 0.490 |
Why?
|
| Antibodies, Monoclonal, Humanized | 3 | 2024 | 554 | 0.480 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2020 | 823 | 0.480 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 267 | 0.480 |
Why?
|
| Chemoradiotherapy | 4 | 2020 | 130 | 0.480 |
Why?
|
| Animals | 38 | 2025 | 36364 | 0.480 |
Why?
|
| Swine Diseases | 3 | 2021 | 42 | 0.470 |
Why?
|
| Serum Albumin, Bovine | 2 | 2025 | 56 | 0.460 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2014 | 232 | 0.450 |
Why?
|
| Hypogonadism | 1 | 2018 | 311 | 0.450 |
Why?
|
| Humans | 69 | 2025 | 133858 | 0.440 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2014 | 16 | 0.440 |
Why?
|
| Microfilament Proteins | 3 | 2018 | 290 | 0.440 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 398 | 0.440 |
Why?
|
| Corpus Striatum | 1 | 2014 | 97 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2014 | 59 | 0.430 |
Why?
|
| Neurons | 2 | 2025 | 2033 | 0.430 |
Why?
|
| Neoplasm Staging | 10 | 2025 | 1387 | 0.430 |
Why?
|
| Acetylcysteine | 3 | 2021 | 85 | 0.420 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 187 | 0.410 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 133 | 0.410 |
Why?
|
| Parkinson Disease | 2 | 2025 | 732 | 0.410 |
Why?
|
| Movement | 1 | 2014 | 180 | 0.400 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 94 | 0.400 |
Why?
|
| Mass Screening | 1 | 2019 | 832 | 0.400 |
Why?
|
| Attention | 1 | 2014 | 209 | 0.400 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 2935 | 0.390 |
Why?
|
| Cleft Palate | 1 | 2014 | 154 | 0.380 |
Why?
|
| Arabidopsis | 2 | 2023 | 94 | 0.380 |
Why?
|
| Intestines | 4 | 2021 | 613 | 0.370 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 349 | 0.360 |
Why?
|
| Antineoplastic Agents | 5 | 2025 | 1850 | 0.350 |
Why?
|
| Ranunculaceae | 1 | 2010 | 1 | 0.350 |
Why?
|
| Weaning | 3 | 2020 | 51 | 0.350 |
Why?
|
| Intestine, Small | 3 | 2018 | 317 | 0.350 |
Why?
|
| Learning | 1 | 2014 | 378 | 0.350 |
Why?
|
| Adult | 21 | 2025 | 31926 | 0.340 |
Why?
|
| Histones | 1 | 2014 | 569 | 0.340 |
Why?
|
| Ceramides | 1 | 2010 | 47 | 0.340 |
Why?
|
| Isoflavones | 2 | 2021 | 46 | 0.340 |
Why?
|
| Middle Aged | 21 | 2025 | 29378 | 0.330 |
Why?
|
| Female | 35 | 2025 | 71588 | 0.330 |
Why?
|
| Prognosis | 14 | 2025 | 5071 | 0.320 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 1334 | 0.320 |
Why?
|
| Male | 33 | 2025 | 65821 | 0.320 |
Why?
|
| Hypertension | 1 | 2018 | 1391 | 0.320 |
Why?
|
| Lactic Acid | 2 | 2020 | 167 | 0.320 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 388 | 0.310 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 689 | 0.310 |
Why?
|
| RNA, Untranslated | 3 | 2007 | 120 | 0.310 |
Why?
|
| RNA, Long Noncoding | 2 | 2024 | 246 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 3476 | 0.290 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 226 | 0.290 |
Why?
|
| DNA Methylation | 4 | 2023 | 1146 | 0.270 |
Why?
|
| Immunotherapy | 4 | 2025 | 747 | 0.270 |
Why?
|
| Acute Coronary Syndrome | 2 | 2022 | 234 | 0.270 |
Why?
|
| Survival Analysis | 6 | 2020 | 1596 | 0.270 |
Why?
|
| Aged | 16 | 2025 | 21722 | 0.260 |
Why?
|
| RNA, Viral | 3 | 2024 | 562 | 0.260 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 3051 | 0.260 |
Why?
|
| Muscle Contraction | 2 | 2016 | 197 | 0.240 |
Why?
|
| Nanocomposites | 1 | 2025 | 6 | 0.240 |
Why?
|
| Zinc Oxide | 1 | 2025 | 12 | 0.240 |
Why?
|
| Bone Regeneration | 1 | 2025 | 24 | 0.240 |
Why?
|
| Titanium | 1 | 2025 | 25 | 0.240 |
Why?
|
| Neoplasms | 4 | 2025 | 3025 | 0.240 |
Why?
|
| STAT6 Transcription Factor | 1 | 2025 | 38 | 0.230 |
Why?
|
| Chromatography, Thin Layer | 3 | 2010 | 50 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 2123 | 0.230 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2016 | 243 | 0.230 |
Why?
|
| Interleukin-4 | 1 | 2025 | 147 | 0.230 |
Why?
|
| Cisplatin | 2 | 2024 | 287 | 0.230 |
Why?
|
| Enteric Nervous System | 1 | 2025 | 43 | 0.230 |
Why?
|
| Prodrugs | 1 | 2025 | 62 | 0.230 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2024 | 14 | 0.230 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 320 | 0.230 |
Why?
|
| Quinolines | 1 | 2025 | 112 | 0.220 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 1911 | 0.220 |
Why?
|
| Fluorouracil | 1 | 2024 | 141 | 0.220 |
Why?
|
| Piperazines | 2 | 2018 | 257 | 0.220 |
Why?
|
| Nomograms | 2 | 2025 | 40 | 0.220 |
Why?
|
| Microspheres | 1 | 2024 | 75 | 0.220 |
Why?
|
| Drug Resistance, Viral | 1 | 2024 | 50 | 0.220 |
Why?
|
| Embryonic Stem Cells | 3 | 2020 | 177 | 0.220 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2024 | 35 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2024 | 3846 | 0.220 |
Why?
|
| Killer Cells, Natural | 5 | 2024 | 357 | 0.220 |
Why?
|
| Indoles | 1 | 2025 | 201 | 0.220 |
Why?
|
| Helminthiasis | 1 | 2025 | 79 | 0.220 |
Why?
|
| Mice | 15 | 2025 | 18881 | 0.210 |
Why?
|
| Mammals | 2 | 2023 | 277 | 0.210 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2023 | 6 | 0.210 |
Why?
|
| DNA Transposable Elements | 1 | 2024 | 188 | 0.210 |
Why?
|
| Rotifera | 1 | 2023 | 3 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 616 | 0.210 |
Why?
|
| Cell Differentiation | 5 | 2022 | 2026 | 0.210 |
Why?
|
| Hydrogels | 1 | 2024 | 110 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2025 | 358 | 0.210 |
Why?
|
| Cucumis sativus | 1 | 2023 | 1 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2023 | 2703 | 0.210 |
Why?
|
| Lymphoma, T-Cell | 1 | 2023 | 65 | 0.210 |
Why?
|
| Databases, Genetic | 1 | 2006 | 501 | 0.210 |
Why?
|
| Genomics | 5 | 2024 | 1676 | 0.200 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 756 | 0.200 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2023 | 50 | 0.200 |
Why?
|
| Exercise Therapy | 1 | 2025 | 180 | 0.200 |
Why?
|
| Blood Pressure | 3 | 2022 | 1411 | 0.200 |
Why?
|
| Lymphocytes | 1 | 2025 | 440 | 0.200 |
Why?
|
| Signal Transduction | 6 | 2025 | 4896 | 0.200 |
Why?
|
| Pyridines | 1 | 2024 | 247 | 0.200 |
Why?
|
| Brassica napus | 1 | 2022 | 6 | 0.200 |
Why?
|
| Arabidopsis Proteins | 1 | 2023 | 60 | 0.200 |
Why?
|
| Brassica | 1 | 2022 | 17 | 0.200 |
Why?
|
| Adenosine | 2 | 2022 | 139 | 0.200 |
Why?
|
| Teaching | 1 | 2024 | 200 | 0.200 |
Why?
|
| Neoadjuvant Therapy | 1 | 2025 | 404 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2025 | 269 | 0.200 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 108 | 0.200 |
Why?
|
| Exosomes | 1 | 2023 | 56 | 0.190 |
Why?
|
| RNA Caps | 1 | 2022 | 32 | 0.190 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2023 | 87 | 0.190 |
Why?
|
| Radiation Oncology | 1 | 2022 | 28 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2024 | 999 | 0.190 |
Why?
|
| Aminopyrine N-Demethylase | 1 | 2021 | 3 | 0.190 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2022 | 64 | 0.190 |
Why?
|
| Neurodegenerative Diseases | 1 | 2025 | 286 | 0.190 |
Why?
|
| DNA, Viral | 2 | 2024 | 499 | 0.190 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2025 | 266 | 0.180 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2023 | 98 | 0.180 |
Why?
|
| Heterochromatin | 1 | 2021 | 49 | 0.180 |
Why?
|
| Spinal Cord Injuries | 1 | 2025 | 333 | 0.180 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 235 | 0.180 |
Why?
|
| DNA Modification Methylases | 1 | 2021 | 52 | 0.180 |
Why?
|
| Seed Storage Proteins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Globulins | 1 | 2021 | 4 | 0.180 |
Why?
|
| Liver Neoplasms | 3 | 2024 | 1410 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2197 | 0.180 |
Why?
|
| Soybean Proteins | 1 | 2021 | 18 | 0.180 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 584 | 0.180 |
Why?
|
| Immunoblotting | 1 | 2021 | 317 | 0.180 |
Why?
|
| Genome, Bacterial | 1 | 2022 | 212 | 0.180 |
Why?
|
| Clinical Decision-Making | 2 | 2020 | 292 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4800 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 272 | 0.170 |
Why?
|
| Antigens, Plant | 1 | 2021 | 42 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2025 | 311 | 0.170 |
Why?
|
| Retrospective Studies | 11 | 2024 | 17460 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 734 | 0.170 |
Why?
|
| HIV-1 | 1 | 2024 | 488 | 0.170 |
Why?
|
| Macrophages | 1 | 2025 | 701 | 0.170 |
Why?
|
| Kidney Diseases | 1 | 2025 | 504 | 0.170 |
Why?
|
| AlkB Homolog 1, Histone H2a Dioxygenase | 1 | 2020 | 1 | 0.170 |
Why?
|
| Coenzyme A Ligases | 1 | 2020 | 12 | 0.170 |
Why?
|
| Fatty Acid Synthases | 1 | 2020 | 14 | 0.170 |
Why?
|
| DNA Demethylation | 1 | 2020 | 10 | 0.170 |
Why?
|
| Lipoprotein Lipase | 1 | 2020 | 60 | 0.170 |
Why?
|
| Cancer-Associated Fibroblasts | 2 | 2017 | 21 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2022 | 279 | 0.160 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 70 | 0.160 |
Why?
|
| Sus scrofa | 2 | 2017 | 127 | 0.160 |
Why?
|
| Young Adult | 7 | 2024 | 9883 | 0.160 |
Why?
|
| Uric Acid | 1 | 2020 | 109 | 0.160 |
Why?
|
| Thyroid Gland | 1 | 2020 | 115 | 0.160 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2019 | 18 | 0.160 |
Why?
|
| Proteomics | 2 | 2023 | 592 | 0.160 |
Why?
|
| Cell Lineage | 3 | 2022 | 369 | 0.160 |
Why?
|
| Social Networking | 1 | 2019 | 19 | 0.160 |
Why?
|
| NADPH Oxidases | 1 | 2020 | 114 | 0.160 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1718 | 0.160 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 75 | 0.160 |
Why?
|
| Drug Therapy | 1 | 2019 | 93 | 0.160 |
Why?
|
| Animals, Newborn | 5 | 2021 | 1045 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2022 | 448 | 0.150 |
Why?
|
| Imidazoles | 2 | 2025 | 217 | 0.150 |
Why?
|
| Glycogen | 1 | 2018 | 66 | 0.150 |
Why?
|
| Radiotherapy | 1 | 2019 | 148 | 0.150 |
Why?
|
| Cell Proliferation | 6 | 2025 | 2539 | 0.150 |
Why?
|
| Vaginal Smears | 1 | 2019 | 52 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 175 | 0.150 |
Why?
|
| Cinnamomum | 1 | 2018 | 1 | 0.150 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 70 | 0.150 |
Why?
|
| Radiotherapy, Conformal | 1 | 2018 | 63 | 0.150 |
Why?
|
| Limit of Detection | 1 | 2018 | 77 | 0.150 |
Why?
|
| Allergens | 1 | 2021 | 278 | 0.150 |
Why?
|
| Models, Biological | 3 | 2020 | 1533 | 0.150 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 60 | 0.150 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 37 | 0.150 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 7204 | 0.150 |
Why?
|
| Connectome | 1 | 2020 | 118 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2024 | 513 | 0.150 |
Why?
|
| Ileum | 1 | 2018 | 136 | 0.150 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 63 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 619 | 0.140 |
Why?
|
| Jejunum | 1 | 2018 | 131 | 0.140 |
Why?
|
| Animal Feed | 1 | 2018 | 83 | 0.140 |
Why?
|
| Plant Oils | 1 | 2018 | 37 | 0.140 |
Why?
|
| Enterocytes | 1 | 2018 | 75 | 0.140 |
Why?
|
| Oncogenes | 1 | 2018 | 179 | 0.140 |
Why?
|
| Temperature | 1 | 2018 | 330 | 0.140 |
Why?
|
| Mice, Inbred ICR | 2 | 2014 | 153 | 0.140 |
Why?
|
| Flavonoids | 2 | 2016 | 87 | 0.140 |
Why?
|
| Pyrans | 1 | 2017 | 10 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 464 | 0.140 |
Why?
|
| Autophagy | 1 | 2021 | 421 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2025 | 3752 | 0.140 |
Why?
|
| Lipoproteins | 1 | 2018 | 192 | 0.140 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 3 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 87 | 0.140 |
Why?
|
| Succinate Dehydrogenase | 1 | 2017 | 9 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 319 | 0.140 |
Why?
|
| Mice, Knockout | 3 | 2025 | 3969 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2020 | 311 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 874 | 0.130 |
Why?
|
| Quinazolines | 1 | 2018 | 184 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 394 | 0.130 |
Why?
|
| Software | 1 | 2022 | 737 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 178 | 0.130 |
Why?
|
| Leukemia | 1 | 2020 | 380 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4771 | 0.130 |
Why?
|
| Social Support | 1 | 2019 | 380 | 0.130 |
Why?
|
| Mutation | 5 | 2025 | 6290 | 0.130 |
Why?
|
| Caenorhabditis elegans | 2 | 2009 | 241 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 310 | 0.130 |
Why?
|
| Anthocyanins | 1 | 2016 | 4 | 0.130 |
Why?
|
| Oncogene Proteins | 1 | 2017 | 151 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2020 | 905 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 13 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 3987 | 0.130 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 298 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2022 | 553 | 0.130 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 97 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 254 | 0.120 |
Why?
|
| Asparaginase | 3 | 2023 | 48 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 279 | 0.120 |
Why?
|
| Health Promotion | 1 | 2019 | 402 | 0.120 |
Why?
|
| Hypolipidemic Agents | 1 | 2017 | 187 | 0.120 |
Why?
|
| Cholesterol | 1 | 2018 | 574 | 0.120 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 129 | 0.120 |
Why?
|
| Molecular Structure | 2 | 2020 | 317 | 0.120 |
Why?
|
| Adolescent | 7 | 2024 | 20517 | 0.120 |
Why?
|
| Protein Binding | 4 | 2022 | 1834 | 0.120 |
Why?
|
| Amino Acids | 1 | 2018 | 688 | 0.120 |
Why?
|
| Cell Line | 2 | 2025 | 2837 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 248 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2021 | 870 | 0.120 |
Why?
|
| Peptide Hydrolases | 1 | 2016 | 151 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2025 | 13010 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2023 | 1124 | 0.110 |
Why?
|
| Cdc20 Proteins | 1 | 2014 | 3 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 352 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 399 | 0.110 |
Why?
|
| Survival Rate | 4 | 2020 | 2207 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2020 | 822 | 0.110 |
Why?
|
| Clone Cells | 1 | 2014 | 180 | 0.110 |
Why?
|
| Antimalarials | 1 | 2014 | 46 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1071 | 0.110 |
Why?
|
| Cell Culture Techniques | 2 | 2020 | 292 | 0.110 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2010 | 49 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 463 | 0.110 |
Why?
|
| Malaria, Falciparum | 1 | 2014 | 72 | 0.110 |
Why?
|
| Motor Cortex | 1 | 2014 | 90 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2014 | 183 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 168 | 0.100 |
Why?
|
| Lignans | 2 | 2010 | 6 | 0.100 |
Why?
|
| Estrogens | 1 | 2016 | 522 | 0.100 |
Why?
|
| Risk | 3 | 2022 | 831 | 0.100 |
Why?
|
| Oxidation-Reduction | 3 | 2021 | 465 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 590 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1790 | 0.100 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2023 | 68 | 0.100 |
Why?
|
| Age Factors | 1 | 2019 | 2975 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 697 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2020 | 878 | 0.100 |
Why?
|
| Plant Proteins | 2 | 2023 | 92 | 0.100 |
Why?
|
| Alkaloids | 2 | 2009 | 37 | 0.100 |
Why?
|
| Genome, Helminth | 2 | 2009 | 12 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 218 | 0.100 |
Why?
|
| Brain Mapping | 1 | 2014 | 404 | 0.090 |
Why?
|
| Apoptosis | 2 | 2020 | 1931 | 0.090 |
Why?
|
| HIV Infections | 1 | 2024 | 2066 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1814 | 0.090 |
Why?
|
| Risk Factors | 4 | 2024 | 11077 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1064 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2020 | 1315 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 5505 | 0.090 |
Why?
|
| Countercurrent Distribution | 1 | 2010 | 1 | 0.090 |
Why?
|
| Psoralea | 1 | 2010 | 1 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 1161 | 0.090 |
Why?
|
| Registries | 1 | 2017 | 1561 | 0.080 |
Why?
|
| Viral Load | 2 | 2024 | 412 | 0.080 |
Why?
|
| Testosterone | 1 | 2016 | 595 | 0.080 |
Why?
|
| Peganum | 1 | 2009 | 1 | 0.080 |
Why?
|
| Base Sequence | 1 | 2014 | 3171 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1046 | 0.080 |
Why?
|
| Anthracyclines | 2 | 2020 | 44 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 1097 | 0.080 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 19 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3970 | 0.080 |
Why?
|
| Linear Models | 1 | 2011 | 723 | 0.080 |
Why?
|
| Chondrocytes | 1 | 2009 | 51 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2010 | 140 | 0.080 |
Why?
|
| Logistic Models | 1 | 2014 | 1908 | 0.080 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2009 | 102 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 170 | 0.070 |
Why?
|
| Remission Induction | 2 | 2020 | 308 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2020 | 246 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2009 | 248 | 0.070 |
Why?
|
| User-Computer Interface | 2 | 2006 | 166 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 1623 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 1070 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 273 | 0.070 |
Why?
|
| Lindera | 1 | 2006 | 1 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2020 | 971 | 0.070 |
Why?
|
| Vimentin | 2 | 2017 | 70 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2006 | 435 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2024 | 6654 | 0.060 |
Why?
|
| Host Factor 1 Protein | 1 | 2006 | 2 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 613 | 0.060 |
Why?
|
| HCT116 Cells | 2 | 2018 | 64 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1607 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2006 | 55 | 0.060 |
Why?
|
| Databases, Protein | 1 | 2006 | 63 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2020 | 3166 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 667 | 0.060 |
Why?
|
| ErbB Receptors | 2 | 2018 | 304 | 0.060 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 94 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2024 | 627 | 0.060 |
Why?
|
| Isoindoles | 1 | 2025 | 4 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2025 | 68 | 0.060 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2025 | 21 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1314 | 0.060 |
Why?
|
| Injections | 1 | 2025 | 159 | 0.060 |
Why?
|
| Interleukin-13 | 1 | 2025 | 101 | 0.060 |
Why?
|
| Upper Extremity | 1 | 2025 | 57 | 0.060 |
Why?
|
| Electric Capacitance | 1 | 2024 | 15 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 544 | 0.060 |
Why?
|
| Copper-transporting ATPases | 1 | 2024 | 26 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2025 | 125 | 0.060 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2025 | 90 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 714 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2025 | 164 | 0.050 |
Why?
|
| Globus Pallidus | 1 | 2024 | 69 | 0.050 |
Why?
|
| Cell Communication | 1 | 2025 | 186 | 0.050 |
Why?
|
| Proteome | 1 | 2006 | 281 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 283 | 0.050 |
Why?
|
| Quality of Life | 2 | 2025 | 2132 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 2025 | 109 | 0.050 |
Why?
|
| Copper | 1 | 2024 | 75 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2024 | 239 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2023 | 83 | 0.050 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 34 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2024 | 68 | 0.050 |
Why?
|
| Flowers | 1 | 2023 | 11 | 0.050 |
Why?
|
| Plant Breeding | 1 | 2023 | 15 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2025 | 177 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 310 | 0.050 |
Why?
|
| Cytokines | 2 | 2021 | 1396 | 0.050 |
Why?
|
| Colectomy | 1 | 2024 | 82 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2009 | 2902 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2025 | 188 | 0.050 |
Why?
|
| Morbidity | 1 | 2024 | 255 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2025 | 335 | 0.050 |
Why?
|
| Fibrosis | 1 | 2025 | 461 | 0.050 |
Why?
|
| Cattle | 1 | 2024 | 588 | 0.050 |
Why?
|
| Phosphate Transport Proteins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2024 | 366 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2024 | 159 | 0.050 |
Why?
|
| Internet | 1 | 2006 | 401 | 0.050 |
Why?
|
| Vacuoles | 1 | 2022 | 31 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 5173 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2024 | 244 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2025 | 431 | 0.050 |
Why?
|
| Phosphates | 1 | 2022 | 119 | 0.050 |
Why?
|
| Australia | 1 | 2022 | 190 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2025 | 827 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2025 | 407 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2022 | 105 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2009 | 951 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2023 | 319 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 609 | 0.040 |
Why?
|
| Aftercare | 1 | 2022 | 157 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2022 | 82 | 0.040 |
Why?
|
| Glycogen Synthase | 1 | 2020 | 7 | 0.040 |
Why?
|
| Spermine | 1 | 2020 | 5 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2024 | 344 | 0.040 |
Why?
|
| Sex Factors | 1 | 2025 | 1384 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2020 | 24 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2022 | 240 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 48 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2020 | 21 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2006 | 1002 | 0.040 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2020 | 1 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2020 | 65 | 0.040 |
Why?
|
| Magnetoencephalography | 1 | 2020 | 36 | 0.040 |
Why?
|
| U937 Cells | 1 | 2020 | 25 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 104 | 0.040 |
Why?
|
| Prostate | 1 | 2023 | 448 | 0.040 |
Why?
|
| Brain | 2 | 2024 | 3217 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 113 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2014 | 828 | 0.040 |
Why?
|
| K562 Cells | 1 | 2020 | 100 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2020 | 131 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 104 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 3691 | 0.040 |
Why?
|
| Radiologists | 1 | 2020 | 51 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 507 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 820 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 173 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 135 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 133 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 395 | 0.040 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2019 | 12 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 332 | 0.040 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2019 | 44 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 307 | 0.040 |
Why?
|
| Picrates | 2 | 2010 | 3 | 0.040 |
Why?
|
| Time Factors | 3 | 2017 | 6583 | 0.040 |
Why?
|
| Hydroxylation | 1 | 2018 | 50 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2022 | 844 | 0.040 |
Why?
|
| Child | 4 | 2020 | 25712 | 0.040 |
Why?
|
| Etoposide | 1 | 2018 | 120 | 0.040 |
Why?
|
| Biphenyl Compounds | 2 | 2010 | 62 | 0.040 |
Why?
|
| Amino Acid Transport Systems | 1 | 2018 | 10 | 0.040 |
Why?
|
| Lung | 2 | 2020 | 1556 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2018 | 62 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2018 | 84 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2018 | 50 | 0.040 |
Why?
|
| Claudins | 1 | 2018 | 31 | 0.040 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2018 | 39 | 0.040 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2018 | 15 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 32 | 0.040 |
Why?
|
| Nucleic Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 518 | 0.040 |
Why?
|
| Indomethacin | 1 | 2018 | 86 | 0.040 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 46 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1126 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 248 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 312 | 0.040 |
Why?
|
| Kidney | 1 | 2025 | 1410 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 239 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 128 | 0.030 |
Why?
|
| ras Proteins | 1 | 2018 | 146 | 0.030 |
Why?
|
| Schools | 1 | 2019 | 233 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 451 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1240 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 449 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 347 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 57 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 26 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 152 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 254 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 318 | 0.030 |
Why?
|
| Plasma | 1 | 2017 | 104 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 124 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2018 | 343 | 0.030 |
Why?
|
| Virus Replication | 1 | 2020 | 638 | 0.030 |
Why?
|
| COP9 Signalosome Complex | 1 | 2016 | 13 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2018 | 225 | 0.030 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 777 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2017 | 363 | 0.030 |
Why?
|
| Diarrhea | 1 | 2018 | 341 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 560 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 2763 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2018 | 482 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 186 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 734 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1485 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 407 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 688 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2016 | 102 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1079 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 814 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 905 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 480 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 352 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 754 | 0.030 |
Why?
|
| Sporozoites | 1 | 2014 | 4 | 0.030 |
Why?
|
| Antimitotic Agents | 1 | 2014 | 2 | 0.030 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2014 | 5 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2014 | 13 | 0.030 |
Why?
|
| HTLV-I Infections | 1 | 2014 | 7 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 271 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2014 | 32 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 91 | 0.030 |
Why?
|
| Spindle Apparatus | 1 | 2014 | 50 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 786 | 0.030 |
Why?
|
| Gene Products, tax | 1 | 2014 | 47 | 0.030 |
Why?
|
| Weight Gain | 1 | 2017 | 414 | 0.030 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2014 | 64 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 1006 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3880 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 194 | 0.030 |
Why?
|
| Plasmodium falciparum | 1 | 2014 | 97 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 717 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2515 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 1483 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1614 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2020 | 14776 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 917 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 508 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 4532 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 364 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1306 | 0.020 |
Why?
|
| Proteins | 1 | 2018 | 1087 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 783 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1196 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3740 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 1757 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3422 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 644 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2011 | 261 | 0.020 |
Why?
|
| Tablets | 1 | 2010 | 36 | 0.020 |
Why?
|
| Autoradiography | 1 | 2010 | 74 | 0.020 |
Why?
|
| Coumarins | 1 | 2010 | 24 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 90 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 160 | 0.020 |
Why?
|
| Acetates | 1 | 2010 | 79 | 0.020 |
Why?
|
| Seeds | 1 | 2009 | 43 | 0.020 |
Why?
|
| Aggrecans | 1 | 2009 | 6 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 2009 | 52 | 0.020 |
Why?
|
| Goats | 1 | 2009 | 60 | 0.020 |
Why?
|
| Argonaute Proteins | 1 | 2009 | 31 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2009 | 25 | 0.020 |
Why?
|
| DNA, Helminth | 1 | 2009 | 23 | 0.020 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2009 | 37 | 0.020 |
Why?
|
| Ethanol | 1 | 2010 | 171 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 54 | 0.020 |
Why?
|
| Algorithms | 2 | 2006 | 1732 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2009 | 103 | 0.020 |
Why?
|
| Cell Separation | 1 | 2009 | 234 | 0.020 |
Why?
|
| Ovary | 1 | 2011 | 384 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2007 | 9 | 0.020 |
Why?
|
| Perilla | 1 | 2006 | 1 | 0.020 |
Why?
|
| Magnolia | 1 | 2006 | 1 | 0.020 |
Why?
|
| Luteolin | 1 | 2006 | 2 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 2006 | 25 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2007 | 97 | 0.020 |
Why?
|
| Hydrazines | 1 | 2006 | 34 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 464 | 0.020 |
Why?
|
| Quality Control | 1 | 2006 | 127 | 0.020 |
Why?
|
| Systems Integration | 1 | 2006 | 28 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 2082 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2006 | 32 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 922 | 0.020 |
Why?
|
| Operon | 1 | 2006 | 53 | 0.020 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2006 | 58 | 0.020 |
Why?
|
| Heme | 1 | 2006 | 54 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 1414 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2006 | 438 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2006 | 173 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 832 | 0.010 |
Why?
|
| Liver | 1 | 2011 | 1867 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2006 | 704 | 0.010 |
Why?
|